Oct 9, 2026 05:52AM

Sep 23, 2026 06:39AM

Aug 11, 2026 05:02PM

May 12, 2026 05:19PM

Apr 22, 2026 05:14AM

Apr 14, 2026 06:48AM

Apr 13, 2026 10:29AM Maze Therapeutics (MAZE) PT Lowered to $64 at Truist Securities

Mar 25, 2026 12:20PM

Mar 25, 2026 12:19PM

Mar 25, 2026 11:45AM

Mar 25, 2026 10:50AM

Mar 25, 2026 09:40AM

Mar 25, 2026 08:30AM

Mar 25, 2026 08:16AM Mizuho on Maze Therapeutics (MAZE): top-line data from Ph2 study shows 'best-in-class' potential

Mar 25, 2026 07:47AM

Mar 25, 2026 07:39AM

Mar 17, 2026 04:28PM

Mar 16, 2026 09:14AM

Mar 10, 2026 04:06AM

Feb 4, 2026 05:22PM

Jan 28, 2026 06:43AM H.C. Wainwright Reiterates Buy Rating on Maze Therapeutics (MAZE)

Dec 19, 2025 07:50AM

Dec 18, 2025 04:10AM

Dec 4, 2025 06:51AM

Dec 4, 2025 05:27AM

Nov 13, 2025 04:06PM

Nov 6, 2025 07:01AM

Oct 17, 2025 04:20PM Maze Therapeutics (MAZE) files for 9.23M share offering by selling stockholders

Oct 3, 2025 06:42AM

Sep 15, 2025 07:29AM

Sep 15, 2025 07:25AM

Sep 12, 2025 07:32AM

Sep 11, 2025 03:56PM

Sep 11, 2025 03:45PM

Sep 2, 2025 06:37AM BTIG Starts Maze Therapeutics (MAZE) at Buy

Aug 12, 2025 04:55PM

Jul 23, 2025 07:48AM

May 15, 2025 05:23PM

Feb 25, 2025 06:29AM

Feb 25, 2025 05:30AM

Feb 25, 2025 12:59AM

Feb 25, 2025 12:58AM JPMorgan Starts Maze Therapeutics (MAZE) at Overweight

Feb 7, 2025 08:01AM

Jan 31, 2025 12:21PM

Jan 27, 2025 06:10AM

479,031 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All